New Hampshire has postponed a pending trial against drugmaker Johnson & Johnson over opioid distribution and marketing from February to September because of COVID-19 concerns.
The state of New Hampshire was scheduled to face a jury trial on Feb. 2 against Johnson & Johnson and Janssen Pharmaceuticals, Inc.
Eight weeks were allotted for the trial in Merrimack County Superior Court, but lawyers and the judge brought up concerns Friday about delays and too few jury members if participants test positive for the COVID-19 virus.
Jury selection is expected to be held after Labor Day.
Copyright 2026 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Was this article valuable?
Here are more articles you may enjoy.
Progressive Insurance Helps First-Time Homebuyers With Down Payments 
Hedge Funds Make Their Move as Litigation Finance Assets Slump 
Most Are Overcharged for Property Insurance, Vanderbilt Study Says 
Florida, Louisiana Insurer Safepoint Reveals 97% Revenue Surge in IPO filing 
